BJTJ-1837, a novel FXI activation-blocking antibody.
He X, Zhang J, Du Y, Liu X, Hu D, Cao B, Gao H, Wu Y, Zhou T, Wu Q, Huang Q, Yang C, Liao C, Zhang L, Shen C, Wang L.
He X, et al. Among authors: yang c.
Res Pract Thromb Haemost. 2023 Feb 7;7(2):100067. doi: 10.1016/j.rpth.2023.100067. eCollection 2023 Feb.
Res Pract Thromb Haemost. 2023.
PMID: 36936858
Free PMC article.